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Association of single nucleotide 
polymorphisms in AXIN2, BMP4, 
and IRF6 with Non-Syndromic Cleft 
Lip with or without Cleft Palate in 
a sample of the southeast Iranian 
population
Non-syndromic cleft lip with or without palate (NSCL/P) is a common 
congenital malformation worldwide, with complex etiology. It has been 
proposed that interaction of genes and environmental factors play a role in 
the predisposition to this disease. Objectives: The aim of this study was to 
examine the association between AXIN2 (axis inhibition protein 2) rs7224837, 
BMP4 (bone morphogenetic protein 4) rs17563, and IRF6 (interferon 
regulatory factor 6) rs861019 and 2235371 polymorphisms and NSCL/P in 
an Iranian population. Material and Methods: This case-control study was 
carried out on 132 unrelated NSCL/P patients and 156 healthy subjects. 
The variants were genotyped using polymerase chain reaction-restriction 
???????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????
codominant (OR=0.36, 95%CI=0.17-0.79, p=0.012, CT vs CC and OR=0.11, 
95%CI=0.01-0.88, p=0.019, TT vs CC), dominant (OR=0.30, 95%CI=0.15-
0.62, p=0.0007, CT+TT vs CC), recessive (OR=0.12, 95%CI=0.02-0.99, 
p=0.023, TT vs CC+CT), overdominant (OR=0.39, 95%CI=0.18-0.84, 
p=0.021, CT vs CC+TT), and allele (OR=0.28, 95%CI=0.15-0.55, p<0.0001, 
?? ??? ??? ???????????????????????? ???????? ???? ???? ???????? ??? ????????????
between AXIN2 rs7224837 and IRF6 rs861019 polymorphism and risk/
protection of NSCL/P. The IRF6 2235371 variant was not polymorphic in our 
population. Conclusion: The results indicate that the BMP4 rs17563 variant 
is likely to confer a protective effect against the occurrence of NSCL/P in a 
sample of the southeast Iranian population. 
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Introduction
Nonsyndromic cleft lip with or without cleft palate 
(NSCL/P) is one of the most common congenital 
malformations among live births worldwide5. The 
prevalence of NSCL/P is about 1.7 per 1000 live births, 
although this rate is different in terms of geographical 
position and ethnicity18, with higher occurrence 
in Asian and Native American populations than in 
African populations. Although the exact etiology of 
NSCL/P is unknown, it is proposed that both genetic 
and environmental factors play a role in the disease’s 
pathogenesis5.
Wnts are a family of signaling molecules that 
play critical roles in diverse aspects of craniofacial 
development. The AXIN2 (axis inhibition protein 2) 
acts as a tumor suppressor gene in numerous cancers 
mapped at human chromosome 17q23-q246. AXIN2 
serves as a scaffolding component of the multiprotein 
???????? ???? ??????????? ?????????????????????????
signaling downstream pathway via degradation of 
?????????2. It has been shown that members of 
the Wnts gene family are associated with clefts in 
humans and mice11. Mutations or polymorphisms 
in AXIN2 have been shown to be associated with 
increased susceptibility to cancer9,10 and familial tooth 
agenesis10,16. 
Bone morphogenetic proteins (BMPs) are secreted 
signaling molecules that belong to the transforming 
growth factor-b (TGF-b) superfamily of growth 
factors. The bone morphogenetic protein 4 (BMP4) 
gene is located at chromosome 14q22-23, contains 
four exons, and encodes the BMP4 protein28, which 
play critical roles in embryonic development. Animal 
models indicated that the BMP4 is a potential 
candidate gene for NSCL/P14. Liu, et al.13 (2005) 
reported that all embryos of BMP4 knockout in a 
mouse model had bilateral CL at the 12th embryonic 
day, demonstrating that the BMP signal pathway is 
critical for cell proliferation and fusion of oral and 
maxillofacial construction. The rs17563 (538T/C) 
functional polymorphism of the BMP4 gene is shown 
to be associated with risk of NSCL/P development 7.
The interferon regulatory factor 6 (IRF6) gene is 
located on chromosome 1q32.2. It has been shown 
that variants of the IRF6 gene increased the risk of 
NSCL/P as well as tooth agenesis20,22,26. 
Genetic risk factors for NSCL/P may be attributed 
to ethnic and environmental differences among 
various populations. Accordingly, repeating previously 
described genetic associations in different populations 
?????????????????????????????????????????????????????
risk in each population. Therefore, this study aimed 
to evaluate the possible association among AXIN2 
rs7224837, BMP4 rs17563, and IRF6 rs861019 and 
2235371 polymorphisms and NSCL/P risk in a sample 
of the southeast Iranian population. 
Materials and Methods
A total of 288 subjects, including 132 NSCL/P 
and 156 healthy subjects, were recruited for this 
case-control study. The criteria for participants with 
NSCL/P and healthy individuals were previously 
described22-24. The local Ethics Committee of the 
Zahedan University of Medical Sciences approved the 
project (IR.ZAUMS.Rec.1393.6923) and informed 
consent forms were collected from all participants (or 
their legal guardians). Blood samples were collected 
in EDTA containing tubes from patients and controls, 
and then stored at -20°C. Genomic DNA was extracted 
by salting-out method. 
Genotyping
Genotyping of AXIN2, BMP4 and IRF6 variants 
was carried out using the polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) 
method. The primers sequences and amplicon sizes 
are shown in Table 1. PCR was performed using 
commercially available Prime Taq premix (Genetbio, 
South Korea) according to the manufacturer’s 
recommended protocol. Into each 0.20 ml PCR 
????????? ??????????? ??? ???????????? ??????????????
???????????????? ??????????????????????????? ??????
??????????????????????????????????????????????????
conditions were initial denaturation at 95°C for 5 min 
followed by 30 cycles for 30 s at 95°C, and annealing 
temperature (Table 1) for 30 s, extension at 72°C for 
????????????????????????????????????????????????????
????????????? ?????????????????????????????????????
restriction enzymes (Table 1) and the digested 
products were electrophoresed on 2.5% agarose gel 
?????????????????????????????????????????????????????
on a UV transilluminator (Figure 1). 
Statistical analysis
All statistical analyses were performed using 
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the SPSS 22.0 software. The associations between 
alleles or genotypes and NS-CL/P were assessed by 
????????????????????????????????????????????????
intervals (95%CI) from unconditional logistic 
regression analyses. P-values less than 0.05 were 
?????????????????????????????????????
Polymorphism NSCL/P Control Patients OR (95%CI) P-value
n (%) n (%)
???????????????????
Codominant
AA 103 (78.0) 125 (80.1) 1 -
AG 25 (19.0) 26 (16.7) 1.17 (0.63-2.14) 0.643
GG 4 (3.0) 5 (3.2) 0.97 (0.25-3.71) 0.973
Dominant
AA 103 (78.0) 125 (80.1) 1 -
AG+GG 29 (22.0) 31 (19.9) 1.14 (0.64-2.01) 0.665
Reccessive
AA+AG 128 (97.0) 151 (96.8) 1
GG 4 (3.0) 5 (3.2) 0.94 (0.25-3.59) 0.944
Overdominant
AA+GG 107 (81.0) 130 (83.3) 1 -
AG 25 (19.0) 26 (16.7) 1.17 (0.64-2.14) 0.644
Allele
A 231 (87.5) 276 (88.4) 1 -
G 33 (12.5) 36 (11.6) 1.09 (0.66-1.81) 0.797
BMP4 rs17563
Codominant
CC 121 (91.7) 120 (76.9) 1 -
CT 10 (7.6) 27 (17.3) 0.36 (0.17-0.79) 0.012
TT 1 (0.7) 9 (5.8) 0.11 (0.01-0.88) 0.019
Dominant
CC 121 (91.7) 120 (76.9) 1 -
CT+TT 11 (8.3) 36 (23.1) 0.30 (0.15-0.62) 0.0007
Recessive
CC+CT 131 (99.3) 147 (94.2) 1 -
TT 1 (0.7) 9 (5.8) 0.12 (0.02-0.99) 0.023
Overdominant
CC+TT 122 (92.4) 129 (82.7) 1 -
CT 10 (7.6) 27 (17.3) 0.39 (0.18-0.84) 0.021
Allele
C 252 (95.4) 267 (85.6) 1 -
T 12 (4.6) 45 (14.4) 0.28 (0.15-0.55) ???????
??????????????????
Codominant
GG 54 (40.9) 50 (32.1) 1 -
GA 63 (47.7) 86 (55.1) 0.68 (0.41-1.12) 0.157
AA 15 (11.4) 20 (12.8) 0.69 (0.32-1.50) 0.435
Dominant
GG 54 (40.9) 50 (32.1) 1 -
GA+AA 78 (59.1) 106 (67.9) 0.68 (0.42-1.01) 0.139
Recessive
GG+GA 117 (88.6) 136 (87.2) 1 -
AA 15 (11.4) 20 (12.8) 0.87 (0.43-1.78) 0.722
Overdominant
GG+AA 69 (52.3) 70 (44.9) 1 -
GA 63 (47.7) 86 (55.1) 0.74 (0.47-1.83) 0.237
Allele
G 171 (64.8) 186 (59.6) 1 -
A 93 (35.2) 126 (40.4) 0.80 (0.57-1.27) 0.228
Table 1- Genotype and allele frequencies of AXIN2, BMP4, and IRF6 polymorphisms in CL/P and control subjects
RAFOGHDOOST H, HASHEMI M, DANESH H, BIZHANI F, BAHARI G, TAHERI M
2017;25(6):650-6
653J Appl Oral Sci.
Results
This study consisted of 132 NSCL/P (78 males, 54 
females, age: 12.13±11.68 years) and 156 healthy 
individuals (94 males, 62 females, age: 11.35±11.81 
years). Of the 132 patients, 52 had CL, 44 had CL with 
CP (CLP), and 36 had CP. There were no statistically 
????????????????????????????????????????????????????
sex and age (p=0.904 and p=0.575, respectively). 
Genotypic and allelic frequencies of AXIN2, BMP4 and 
IRF6 polymorphisms are shown in Table 2. 
The findings revealed that BMP4 rs17563 
polymorphism significantly decreased the risk of 
NSCL/P in codominant (OR=0.36, 95%CI=0.17-0.79, 
p=0.012, CT vs CC and OR=0.11, 95%CI=0.01-
0.88, p=0.019, TT vs CC), dominant (OR=0.30, 
95%CI=0.15-0.62, p=0.0007, CT+TT vs CC), recessive 
(OR=0.12, 95%CI=0.02-0.99, p=0.023, TT vs 
CC+CT), and overdominant (OR=0.39, 95%CI=0.18-
0.84, p=0.021, CT vs CC+TT) inheritance models. 
???????????????????????????????????????????????????????
(OR=0.28, 95%CI=0.15-0.55, p<0.0001), compared 
to the C allele. 
???????????????????????????????????????????????????
AXIN2 rs7224837 and IRF6 rs861019 polymorphisms 
and risk/protection of CL/P in any inheritance model 
tested (Table 1). In addition, The IRF6 rs2235371 
variant was not polymorphic and all cases (including 
controls) were CC genotype.
We also analyzed gene-gene interaction (Table 2). 
In comparison to the reference IRF6 rs861019 GG, 
BMP4 rs17563 CC, AXIN2 rs7224837 CC, and the 
??????????????????????????????????????????????????
of NSCL/P (OR=0.23, 95%CI=0.07-0.75, p=0.013). 
????????????????????????????????????????????????????
cleft lip with cleft palate (CLP), and cleft palate (CP) 
and assessed the impact of the polymorphisms and 
IRF6 rs861019 BMb4 rs17563 Axin2  rs7224837 Cases Controls OR (95%CI) p
n (%) n (%)
GG CC AA 41 (31.1) 35 (22.4) 1 -
GA CC AA 44 (33.6) 51 (32.7) 0.74 (0.40-1.35) 0.357
AA CC AA 11 (8.3) 10 (6.4) 0.94 (0.36-2.47) 0.939
GG CT AA 2 (1.5) 5 (3.2) 0.34 (0.06-1.87) 0.254
GA CC AG 12 (9.1) 9 (5.8) 1.14 (0.43-3.02) 0.945
GA CT AA 4 (3.0) 15 (9.6) 0.23 (0.07-0.75) 0.013
GG CC AG 7 (5.3) 4 (2.6) 1.49 (0.40-5.53) 0.747
GG TT AA 1 (0.8) 4 (2.6) 0.21 (0.02-2.00) 0.19
AA CC AG 3 (2.3) 7 (4.5) 0.36 (0.09-1.52) 0.191
GG CT AG 1 (0.8) 1 (0.6) 0.85 (0.05-14.16) 0.912
GA CT AG 1 (0.8) 3 (1.9) 0.28 (0.03-2.86) 0.341
AA CT AG 1 (0.8) 1 (0.6) 0.85 (0.05-14.16) 0.912
GG CC GG 2 (1.5) 1 (0.6) 1.71 (0.15-19.65) 0.933
GA CC GG 1 (0.8) 2 (1.3) 0.42 (0.04-4.91) 0.597
GA CT GG 1 (0.8) 1 (0.6) 0.85 (0.05-14.16) 0.912
AA CC GG 0 (0.0) 1 (0.6) - -
AA CT AA 0 (0.0) 1 (0.6) - -
GA TT AA 0 (0.0) 4 (2.6) - -
GA TT AG 0 (0.0) 1 (0.6) - -
Table 2 - Frequency distribution of genotypes combinations for the IRF6 rs861019, and BMP4 rs17563, and AXIN2 rs7224837polymorphisms 
between patients with nonsyndromic cleft lip and/or cleft palate (NSCL/P) and control subjects
Figure 1- The primers and restriction enzymes used for detection of AXIN2, BMP4, and IRF6 polymorphisms using PCR-RFLP methods
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the risk of the disease by comparing with the controls 
????????????????????????????????????????????????????
???????? ???? ????????????? ???????????????? ?????????
risk of CL, CLP, and CP. AXIN2 rs7224837 and IRF6 
rs861019 were not associated with the risk of CL, 
CLP, or CP.
Discussion 
The documentation of risk factors according 
to ethnicity and geographic origin is important for 
understanding the major causes of NSCL/P.
We have previously shown an association between 
FGF1 rs34010, CDH1 rs16260, MSX1 rs12532 and 
DHFR 19-bp insertion/deletion polymorphisms 
and NSCL/P in a sample of the southeast Iranian 
population22-24. In this study, we examined the impact 
Polymorphism Controls CL OR (95%CI), p CLP OR (95%CI), p2 CP OR (95%CI), p3
(n) (n) (n) (n)
Axin2 rs7224837 
AA 125 41 1 35 1 27 1
AG 26 9 1.06 (0.46-2.44), 0.953 7 0.96 (0.38-2/40), 0.911 9 1.60 (0.67-3.81), 0.341
GG 5 2 1.22 (0.23-6.53), 0.917 2 1.43 (0.27-7.68), 0.651 0 -
A 276 91 1 77 1 63 1
C 36 13 1.09 (0.56-2.16), 0.861 11 1.09 (0.53-2.25), 0.851 9 1.09 (0.50-2.39), 0.839
BMP4 rs17563
CC 120 48 1 39 1 34 1
CT 27 3 0.28 (0.08-0.96), 0.040 5 0.57 (0.21-1.58), 0.360 2 0.26 (0.06-1.16), 0.074
TT 9 1 0.28 (0.03-2.54), 0.288 0 3.05 (0.06-156.4), 0.983 0 0.18 (0.01-3.24), 0.206
C 267 99 1 83 1 70 1
T 45 5 0.30 (0.12-0.78), 0.008 5 0.36 (0.14-0.93), 0.028 2 0.17 (0.04-0.72), 0.005
IRF6 rs861019
GG 50 22 1 14 1 18 1
GA 86 25 0.66 (0.34-1.29), 0.231 25 1.04 (0.49-2.18), 0.912 13 0.42 (0.19-0.93), 0.042
AA 20 5 0.57 (0.19-1.71), 0.438 5 0.89 (0.28-2.81), 0.927 5 0.69 (0.23-2.13), 0.598
G 186 69 1 53 1 49 1
A 126 35 0.75 (0.47-1.19), 0.246 35 0.98 (0.60-1.58), 0.965 23 0.69 (0.40-1.19), 0.227
Table 3- Genotype and allele frequencies of AXIN2 rs7224837, BMP4 rs17563, and IRF6 rs861019 gene polymorphisms in subjects with 
cleft lip (CL), cleft lip with cleft palate (CLP), and cleft palate (CP)
Figure 2- Photograph of electrophoresis pattern of the PCR-RFLP method for detection of AXIN2 rs7224837 (A), BMP4 rs17563 (B), IRF6 
??????????????????????????????????? ?????? ??????????? ?????????????????????????????????????????????? ??????????????????? ????????????
??????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
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of AXIN2, BMP4 and IRF6 polymorphisms on the risk 
of NSCL/P. The results suggested that BMP4 rs17563 
polymorphism significantly decreased the risk of 
NSCL/P in codominant, dominant, recessive, and 
??????? ??????????????????????????????????????????????
was found between AXIN2 rs7224837 and IRF6 
rs861019 variants and risk of NSCL/P. We observed 
that rs2235371 polymorphism of the IRF6 gene was 
not polymorphic, and all cases (including controls) 
were CC genotype. 
Letra, et al.12? ??????? ????? ?????? ?? ???????????
association between AXIN2 rs7224837 variant and 
risk of NSCL/P in various populations, including 
Latin America, Europe, and Asia. Mostowska, et al.19 
(2012) have found that rs3923087 polymorphism was 
associated with decreased risk of NSCL/P in a Polish 
?????????????????????????????????????????????????????
between rs4074947, rs7224837, and rs2240308 
variants of AXIN2 and the risk of the disease. A meta-
analysis performed by Wang, et al.30 (2012) showed 
????? ?????????? ???????? ????????????? ?????????? ????
risk of NSCL/P. Recently, Machado, et al.15 (2017) 
showed that the minor A allele of rs7210356 as 
and the T-G-G-A-G haplotype formed by rs7591, 
rs7210356, rs4791171, rs11079571, and rs3923087 
??????????????????????????????????????????????????
associated with NSCL/P in the Brazilian population.
Mijiti, et al.17 (2015) investigated the impact 
of several polymorphisms of the IRF6 gene on 
NSCL/P in Xinjiang, China. They observed that the 
?????????????????????????????????????????????????? ?????
rs2235377, rs2235371, 209968684, rs2013162, and 
rs861019 variants were associated with decreased 
risk of NSCL/P. The other variants were not associated 
with risk of NSCL/P.
Several previous studies have shown that BMP4 
can be implicated in the development of CL/P. A meta-
analysis performed by Hu, et al.7 (2015) showed that 
the BMP4 rs17563 variant could play a different role in 
NSCL/P according to ethnicity diversity. In the Chinese 
?????????????????????????????????????????????????????????
of NSCL/P while it presented a protective effect in the 
Brazilian population1,7. On the other hand, Chen, et al.4 
(2012) reported that this variant was not associated 
with NSCL/P in an Asian population. 
The association of IRF6 rs2235371 polymorphism 
and NSCL/P has been extensively investigated, but 
?????????????????????? ?????????????3,8,17,20,21,27,29. Tang, 
et al.27 (2009) reported that the T allele of rs2235371 
may confer an increased risk of developing cleft in 
Chinese individuals. In contrast, another Chinese 
study has revealed that the rs2235371 variant appears 
to be protective17. In this study, we found that this 
variant is not polymorphic in our population. It has 
been reported that 12% of the genetic contributions 
to CL/P is related to IRF6 variants. The rs2235371 
variant of IRF6 was established to increase the rate 
of recurrence of cleft condition to 9%33. Souza, et 
al.26 (2016) reported that the IRF6 G/A haplotype 
(rs2235371/rs642961) increased the risk for oral 
cleft in the Brazilian population. A meta-analysis 
performed by Wattanawong, et al.31 (2016) showed 
that the IRF6 rs2235371 variant decreased the risk 
of NSCL/P for Asian populations but not Caucasian 
populations. They reported that the rs2013162 
variant decreased the risk of NSCL/P in Caucasian 
??????????????????? ??????????????????????????????????
suggest that rs642961 and rs987525 variants of IRF6 
???????????????????????????????????????????????????????
and Caucasian populations31. Xu, et al.32 (2016) found 
that rs2235371 and rs2013162 polymorphisms of IRF6 
were associated with NSCP in the Chinese population. 
Recently, Salagovic, et al.25 (2017) reported that the 
IRF6 ?????????????????????????????????????????????????
of NSCL/P in the Slovakian population. 
The inconsistent results may arise from different 
ethnic origins, environmental differences, and the 
complex genetic etiology of the NSCL/P disease. 
One of the limitations of this study is its relatively 
small sample sizes. Another limitation is that we 
evaluated limited variants of the AXIN2, BMP4, and 
IRF6. Other genetic variants of these genes should 
also be evaluated.
In conclusion, we performed an association study 
of AXIN2, BMP4 and IRF6 gene SNPs with NSCL/P 
??? ??? ??????????????????????? ?????????????????????
that BMP4 rs17563 polymorphism is associated with 
reduced risk against NSCL/P. Future studies with 
larger samples from different ethnicities are needed 
??????????????????????
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